Analysis of time to each exacerbation during the treatment period
| Exacerbation | Risk ratio (FP 200 μ g:100 μ g) | 95% CI | No. of patients (FP 200 μg, 100 μg twice daily) |
|---|---|---|---|
| *p=0.182. | |||
| Each | 0.85 | (0.67 to 1.08)* | 128, 141 |
| First | 0.85 | (0.67 to 1.08) | 128, 141 |
| Second | 0.88 | (0.64 to 1.20) | 73, 82 |
| Third | 0.75 | (0.48 to 1.18) | 34, 44 |
| Fourth | 0.60 | (0.34 to 1.07) | 19, 30 |
| Fifth | 0.37 | (0.17 to 0.79) | 9, 23 |
| Sixth | 0.60 | (0.26 to 1.40) | 9, 14 |
| Seventh | 0.66 | (0.25 to 1.75) | 7, 10 |
| Eighth | 1.08 | (0.31 to 3.77) | 5, 5 |